Related Experiment Video
Updated: Feb 25, 2026

04:36
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
Published on: October 17, 2025
1.0K
FLT3 inhibition in acute myeloid leukaemia
Naval Daver1, Hagop Kantarjian1
1Department of Leukemia, MD Anderson Cancer Center, Houston, TX 77030, USA.
The Lancet. Oncology
|August 1, 2017
Abstract
No abstract available in PubMed .

